Index by author

01 May 2002; volume 19, issue 5

A

  1. Aalbers, R.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  2. Abdel Kafi, S.

    1. Abdel Kafi, S. et al "Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall." European Respiratory Journal 19.5 (2002): 919-927. Web. 14 April. 2021.

  3. Acuña, A.A.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  4. Alving, K.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

  5. Anzueto, A.

    1. Anzueto, A.. "Exogenous surfactant in acute respiratory distress syndrome: more is better." European Respiratory Journal 19.5 (2002): 787-789. Web. 14 April. 2021.

  6. Athanasakis, H.

    1. Kondili, E. et al "Lung emptying in patients with acute respiratory distress syndrome: effects of positive end-expiratory pressure." European Respiratory Journal 19.5 (2002): 811-819. Web. 14 April. 2021.

  7. Ayres, J.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

B

  1. Backer, V.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  2. Barberà, J.A.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  3. Barreiro, B.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  4. Bateman, E.D.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  5. Behr, J.

    1. Behr, J. et al "Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine." European Respiratory Journal 19.5 (2002): 906-911. Web. 14 April. 2021.

  6. Benzing, A.

    1. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  7. Bernadich, O.

    1. Ferrer, M. et al "Noninvasive ventilation after intubation and mechanical ventilation." European Respiratory Journal 19.5 (2002): 959-965. Web. 14 April. 2021.

  8. Bettens, F.

    1. Libura, J. et al "Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene." European Respiratory Journal 19.5 (2002): 912-918. Web. 14 April. 2021.

  9. Bomans, P.

    1. Willaert, W. et al "What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?." European Respiratory Journal 19.5 (2002): 928-935. Web. 14 April. 2021.

  10. Burge, P.S.

    1. Thickett, K.M. et al "Occupational asthma caused by chloramines in indoor swimming-pool air." European Respiratory Journal 19.5 (2002): 827-832. Web. 14 April. 2021.

C

  1. Carroll, N.G.

    1. Carroll, N.G., S. Mutavdzic, and A.L. James. "Distribution and degranulation of airway mast cells in normal and asthmatic subjects." European Respiratory Journal 19.5 (2002): 879-885. Web. 14 April. 2021.

  2. Chan-Yeung, M.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

  3. Chung, K.F.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  4. Cormier, Y.

    1. Israël-Assayag, E., and Y. Cormier. "Adaptation to organic dust exposure: a potential role of l-selectin shedding?." European Respiratory Journal 19.5 (2002): 833-837. Web. 14 April. 2021.

  5. Costabel, U.

    1. Demedts, M., and U. Costabel. "ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias." European Respiratory Journal 19.5 (2002): 794-796. Web. 14 April. 2021.

D

  1. Daenen, M.

    1. Willaert, W. et al "What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?." European Respiratory Journal 19.5 (2002): 928-935. Web. 14 April. 2021.

  2. Decramer, M.

    1. Willaert, W. et al "What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?." European Respiratory Journal 19.5 (2002): 928-935. Web. 14 April. 2021.
    2. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  3. Degenkolb, B.

    1. Behr, J. et al "Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine." European Respiratory Journal 19.5 (2002): 906-911. Web. 14 April. 2021.

  4. de Jongste, J.C.

    1. Merkus, P.J.F.M., H.A.W.M. Tiddens, and J.C. de Jongste. "Annual lung function changes in young patients with chronic lung disease." European Respiratory Journal 19.5 (2002): 886-891. Web. 14 April. 2021.

  5. de Klerk, N.H.

    1. Oddy, W.H. et al "The effects of respiratory infections, atopy, and breastfeeding on childhood asthma." European Respiratory Journal 19.5 (2002): 899-905. Web. 14 April. 2021.

  6. Demedts, M.

    1. Demedts, M., and U. Costabel. "ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias." European Respiratory Journal 19.5 (2002): 794-796. Web. 14 April. 2021.

  7. den Heeten, G.J.

    1. Kesecioglu, J. et al "Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome." European Respiratory Journal 19.5 (2002): 820-826. Web. 14 April. 2021.

  8. Dorca, J.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

E

  1. Ehrlich, R.I.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  2. Enarson, D.A.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

F

  1. Ferrer, M.

    1. Ferrer, M. et al "Noninvasive ventilation after intubation and mechanical ventilation." European Respiratory Journal 19.5 (2002): 959-965. Web. 14 April. 2021.

  2. Frischer, T.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

G

  1. Gabrijelcic, J.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  2. Garcia, L.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  3. Gartner, C.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  4. Georgopoulos, D.

    1. Kondili, E. et al "Lung emptying in patients with acute respiratory distress syndrome: effects of positive end-expiratory pressure." European Respiratory Journal 19.5 (2002): 811-819. Web. 14 April. 2021.

  5. Gerber, J.M.

    1. Thickett, K.M. et al "Occupational asthma caused by chloramines in indoor swimming-pool air." European Respiratory Journal 19.5 (2002): 827-832. Web. 14 April. 2021.

  6. Grimminger, F.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.
    2. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  7. Gudiol, F.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  8. Günther, A.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.
    2. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

H

  1. Haitsma, J.J.

    1. Kesecioglu, J. et al "Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome." European Respiratory Journal 19.5 (2002): 820-826. Web. 14 April. 2021.

  2. Harodt, J.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.

  3. He, G-X.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

  4. Hoet, P.H.M.

    1. Nemery, B., P.H.M. Hoet, and D. Nowak. "Indoor swimming pools, water chlorination and respiratory health." European Respiratory Journal 19.5 (2002): 790-793. Web. 14 April. 2021.

  5. Holt, P.G.

    1. Oddy, W.H. et al "The effects of respiratory infections, atopy, and breastfeeding on childhood asthma." European Respiratory Journal 19.5 (2002): 899-905. Web. 14 April. 2021.

  6. Horak, F.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

I

  1. Ide, M.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

  2. Israël-Assayag, E.

    1. Israël-Assayag, E., and Y. Cormier. "Adaptation to organic dust exposure: a potential role of l-selectin shedding?." European Respiratory Journal 19.5 (2002): 833-837. Web. 14 April. 2021.

J

  1. James, A.L.

    1. Carroll, N.G., S. Mutavdzic, and A.L. James. "Distribution and degranulation of airway mast cells in normal and asthmatic subjects." European Respiratory Journal 19.5 (2002): 879-885. Web. 14 April. 2021.

  2. Janicki, S.

    1. Richter, K. et al "Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline." European Respiratory Journal 19.5 (2002): 865-871. Web. 14 April. 2021.

  3. Jörres, R.A.

    1. Richter, K. et al "Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline." European Respiratory Journal 19.5 (2002): 865-871. Web. 14 April. 2021.

K

  1. Kalyoncu, A.F.

    1. Kalyoncu, A.F.. "Symptoms of asthma, bronchial responsiveness and atopy in immigrants and emigrants in Europe." European Respiratory Journal 19.5 (2002): 980-983. Web. 14 April. 2021.

  2. Kauppinen, R.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

  3. Kesecioglu, J.

    1. Kesecioglu, J. et al "Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome." European Respiratory Journal 19.5 (2002): 820-826. Web. 14 April. 2021.

  4. Kido, H.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

  5. Knothe, C.

    1. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  6. Kondili, E.

    1. Kondili, E. et al "Lung emptying in patients with acute respiratory distress syndrome: effects of positive end-expiratory pressure." European Respiratory Journal 19.5 (2002): 811-819. Web. 14 April. 2021.

  7. Krombach, F.

    1. Behr, J. et al "Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine." European Respiratory Journal 19.5 (2002): 906-911. Web. 14 April. 2021.

L

  1. Lachmann, B.

    1. Kesecioglu, J. et al "Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome." European Respiratory Journal 19.5 (2002): 820-826. Web. 14 April. 2021.

  2. Leduc, D.

    1. Abdel Kafi, S. et al "Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall." European Respiratory Journal 19.5 (2002): 919-927. Web. 14 April. 2021.

  3. Leuchte, H.

    1. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  4. Li, B.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

  5. Libura, J.

    1. Libura, J. et al "Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene." European Respiratory Journal 19.5 (2002): 912-918. Web. 14 April. 2021.

  6. Lier, P.A.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  7. Lundberg, J.O.N.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

M

  1. Magnussen, H.

    1. Richter, K. et al "Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline." European Respiratory Journal 19.5 (2002): 865-871. Web. 14 April. 2021.

  2. Magyar, P.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  3. Malolepszy, J.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  4. Manresa, F.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  5. Marteus, H.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

  6. Martinez, M.Á.

    1. Morales, P. et al "Severe lung involvement in systemic scleromyxoedema: a highly unusual finding." European Respiratory Journal 19.5 (2002): 976-979. Web. 14 April. 2021.

  7. McCoach, J.S.

    1. Thickett, K.M. et al "Occupational asthma caused by chloramines in indoor swimming-pool air." European Respiratory Journal 19.5 (2002): 827-832. Web. 14 April. 2021.

  8. Merkus, P.J.F.M.

    1. Merkus, P.J.F.M., H.A.W.M. Tiddens, and J.C. de Jongste. "Annual lung function changes in young patients with chronic lung disease." European Respiratory Journal 19.5 (2002): 886-891. Web. 14 April. 2021.

  9. Morales, P.

    1. Morales, P. et al "Severe lung involvement in systemic scleromyxoedema: a highly unusual finding." European Respiratory Journal 19.5 (2002): 976-979. Web. 14 April. 2021.

  10. Mutavdzic, S.

    1. Carroll, N.G., S. Mutavdzic, and A.L. James. "Distribution and degranulation of airway mast cells in normal and asthmatic subjects." European Respiratory Journal 19.5 (2002): 879-885. Web. 14 April. 2021.

N

  1. Nava, S.

    1. Ferrer, M. et al "Noninvasive ventilation after intubation and mechanical ventilation." European Respiratory Journal 19.5 (2002): 959-965. Web. 14 April. 2021.

  2. Nelson, H.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  3. Nemery, B.

    1. Nemery, B., P.H.M. Hoet, and D. Nowak. "Indoor swimming pools, water chlorination and respiratory health." European Respiratory Journal 19.5 (2002): 790-793. Web. 14 April. 2021.

  4. Niederman, M.S.

    1. Sohy, C. et al "Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?." European Respiratory Journal 19.5 (2002): 966-975. Web. 14 April. 2021.

  5. Nieminen, M.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

  6. Ninane, V.

    1. Abdel Kafi, S. et al "Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall." European Respiratory Journal 19.5 (2002): 919-927. Web. 14 April. 2021.

  7. Nowak, D.

    1. Nemery, B., P.H.M. Hoet, and D. Nowak. "Indoor swimming pools, water chlorination and respiratory health." European Respiratory Journal 19.5 (2002): 790-793. Web. 14 April. 2021.

O

  1. Obertacke, U.

    1. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  2. Oddy, W.H.

    1. Oddy, W.H. et al "The effects of respiratory infections, atopy, and breastfeeding on childhood asthma." European Respiratory Journal 19.5 (2002): 899-905. Web. 14 April. 2021.

  3. Ohuchi, M.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

  4. Okumura, Y.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

P

  1. Pappert, D.

    1. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  2. Parnell, S.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  3. Picado, C.

    1. Plaza, V. et al "Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma." European Respiratory Journal 19.5 (2002): 846-852. Web. 14 April. 2021.

  4. Piguet, P.F.

    1. Libura, J. et al "Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene." European Respiratory Journal 19.5 (2002): 912-918. Web. 14 April. 2021.

  5. Pilette, C.

    1. Sohy, C. et al "Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?." European Respiratory Journal 19.5 (2002): 966-975. Web. 14 April. 2021.

  6. Plaza, V.

    1. Plaza, V. et al "Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma." European Respiratory Journal 19.5 (2002): 846-852. Web. 14 April. 2021.

  7. Poyser, M.A.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  8. Prats, E.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  9. Prinianakis, G.

    1. Kondili, E. et al "Lung emptying in patients with acute respiratory distress syndrome: effects of positive end-expiratory pressure." European Respiratory Journal 19.5 (2002): 811-819. Web. 14 April. 2021.

  10. Pujol, M.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  11. Puterman, A.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

R

  1. Rabinovich, R.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  2. Radkowski, A.

    1. Libura, J. et al "Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene." European Respiratory Journal 19.5 (2002): 912-918. Web. 14 April. 2021.

  3. Richter, K.

    1. Richter, K. et al "Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline." European Respiratory Journal 19.5 (2002): 865-871. Web. 14 April. 2021.

  4. Roca, J.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  5. Rodriguez-Roisin, R.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

  6. Romero, G.

    1. Morales, P. et al "Severe lung involvement in systemic scleromyxoedema: a highly unusual finding." European Respiratory Journal 19.5 (2002): 976-979. Web. 14 April. 2021.

  7. Ruffin, R.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

  8. Ruppert, C.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.

S

  1. Sadhra, S.

    1. Thickett, K.M. et al "Occupational asthma caused by chloramines in indoor swimming-pool air." European Respiratory Journal 19.5 (2002): 827-832. Web. 14 April. 2021.

  2. Sanchis, J.

    1. Plaza, V. et al "Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma." European Respiratory Journal 19.5 (2002): 846-852. Web. 14 April. 2021.

  3. Schedin, U.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

  4. Schmehl, T.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.
    2. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  5. Schmidt, R.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.

  6. Schultz, M.J.

    1. Kesecioglu, J. et al "Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome." European Respiratory Journal 19.5 (2002): 820-826. Web. 14 April. 2021.

  7. Seeger, W.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.
    2. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  8. Sergysels, R.

    1. Abdel Kafi, S. et al "Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall." European Respiratory Journal 19.5 (2002): 919-927. Web. 14 April. 2021.

  9. Serrano, J.

    1. Plaza, V. et al "Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma." European Respiratory Journal 19.5 (2002): 846-852. Web. 14 April. 2021.

  10. Sersté, T.

    1. Abdel Kafi, S. et al "Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall." European Respiratory Journal 19.5 (2002): 919-927. Web. 14 April. 2021.

  11. Sibille, Y.

    1. Sohy, C. et al "Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?." European Respiratory Journal 19.5 (2002): 966-975. Web. 14 April. 2021.

  12. Sly, P.D.

    1. Oddy, W.H. et al "The effects of respiratory infections, atopy, and breastfeeding on childhood asthma." European Respiratory Journal 19.5 (2002): 899-905. Web. 14 April. 2021.

  13. Sohy, C.

    1. Sohy, C. et al "Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?." European Respiratory Journal 19.5 (2002): 966-975. Web. 14 April. 2021.

  14. Spengler, J.D.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  15. Studnicka, M.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  16. Sybrecht, G.W.

    1. Aalbers, R. et al "Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial." European Respiratory Journal 19.5 (2002): 936-943. Web. 14 April. 2021.

T

  1. Tauber, E.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  2. Thickett, K.M.

    1. Thickett, K.M. et al "Occupational asthma caused by chloramines in indoor swimming-pool air." European Respiratory Journal 19.5 (2002): 827-832. Web. 14 April. 2021.

  3. Tiddens, H.A.W.M.

    1. Merkus, P.J.F.M., H.A.W.M. Tiddens, and J.C. de Jongste. "Annual lung function changes in young patients with chronic lung disease." European Respiratory Journal 19.5 (2002): 886-891. Web. 14 April. 2021.

  4. Tiercy, J.M.

    1. Libura, J. et al "Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene." European Respiratory Journal 19.5 (2002): 912-918. Web. 14 April. 2021.

  5. Törnberg, D.C.F.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

  6. Torres, A.

    1. Ferrer, M. et al "Noninvasive ventilation after intubation and mechanical ventilation." European Respiratory Journal 19.5 (2002): 959-965. Web. 14 April. 2021.

  7. Tu, D-H.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.

U

  1. Urbanek, R.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  2. Uribe, E.M.

    1. Acuña, A.A. et al "Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma." European Respiratory Journal 19.5 (2002): 872-878. Web. 14 April. 2021.

V

  1. Veiter, A.

    1. Horak, F. et al "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 19.5 (2002): 838-845. Web. 14 April. 2021.

  2. Vera, F.

    1. Morales, P. et al "Severe lung involvement in systemic scleromyxoedema: a highly unusual finding." European Respiratory Journal 19.5 (2002): 976-979. Web. 14 April. 2021.

  3. Verdaguer, R.

    1. Prats, E. et al "Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia." European Respiratory Journal 19.5 (2002): 944-951. Web. 14 April. 2021.

  4. Verleden, G.

    1. Willaert, W. et al "What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?." European Respiratory Journal 19.5 (2002): 928-935. Web. 14 April. 2021.

  5. Vogelmeier, C.

    1. Behr, J. et al "Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine." European Respiratory Journal 19.5 (2002): 906-911. Web. 14 April. 2021.

W

  1. Walmrath, D.

    1. Günther, A. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties." European Respiratory Journal 19.5 (2002): 797-804. Web. 14 April. 2021.
    2. Walmrath, D. et al "Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics." European Respiratory Journal 19.5 (2002): 805-810. Web. 14 April. 2021.

  2. Weinberg, E.

    1. Poyser, M.A. et al "Socioeconomic deprivation and asthma prevalence and severity in young adolescents." European Respiratory Journal 19.5 (2002): 892-898. Web. 14 April. 2021.

  3. Weitzberg, E.

    1. Törnberg, D.C.F. et al "Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients." European Respiratory Journal 19.5 (2002): 859-864. Web. 14 April. 2021.

  4. Willaert, W.

    1. Willaert, W. et al "What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?." European Respiratory Journal 19.5 (2002): 928-935. Web. 14 April. 2021.

Y

  1. Yang, B.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

  2. Yano, M.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

  3. Yao, D.F.

    1. Yang, B. et al "Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels." European Respiratory Journal 19.5 (2002): 952-958. Web. 14 April. 2021.

Z

  1. Zhang, L-X.

    1. Chan-Yeung, M. et al "The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China." European Respiratory Journal 19.5 (2002): 853-858. Web. 14 April. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts